Global Point of Care
i-STAT in critical care
REAL-time lab results for critical care.
i-STAT empowers your critical care team to scale capacity, improve patient care and help ensure staff safety.
Today, critical care departments such as the Intensive Care (ICU), Cardiovascular ICU (CICU), Neonatal Intensive Care Unit (NICU), and Coronary Care Unit are being shaped by the need to meet established goal-directed therapy, vent weaning and patient safety protocols. Additional issues associated with critical care include blood loss and the need to reduce patient length of stay (LOS) and costs from delays and prolonged treatments.
The i-STAT System provides clinicians with greater control over patient management by providing lab-quality results in minutes. Additionally, quality checks of sample integrity, sensors, and fluidics are automatic with each i-STAT single-use test cartridge, providing confidence and advanced performance.
Using just two to three drops of blood, the i‑STAT System analyzes the patient sample with minimal steps – reducing the traditional pre-analytical steps to just one.
Real-time lab results for critical care.
i‑STAT empowers your critical care team to scale capacity, improve patient care and help ensure staff safety.
Today, critical care departments such as the Intensive Care (ICU), Cardiovascular ICU (CICU), Neonatal Intensive Care Unit (NICU), and Coronary Care Unit are being shaped by the need to meet established goal-directed therapy, vent weaning and patient safety protocols. Additional issues associated with critical care include blood loss and the need to reduce patient length of stay (LOS) and costs from delays and prolonged treatments.
The i-STAT System provides clinicians with greater control over patient management by providing lab-quality results in minutes. Additionally, quality checks of sample integrity, sensors, and fluidics are automatic with each i-STAT single-use test cartridge, providing confidence and advanced performance.
Using just two to three drops of blood, the i‑STAT
System analyzes the patient sample with minimal steps – reducing the
traditional pre-analytical steps to just one.
Meeting the current challenges of critical care delivery
In this intense environment that healthcare professionals are currently facing, the primary focus for many hospitals has become:
expanding capacity
conserving resources
maintaining safety
maintaining the
highest standards of
care
every drop matters
The i-STAT System requires only two to three drops of blood to deliver lab-quality results. This is vital in the Neonatal Itensive Care Unit (NICU) where babies can lose up to 15% of their total circulating blood volume during a two-week stay in the NICU -- blood that will not be quickly replaced by immature neonatal bone marrow.1
i-STAT can significantly reduce blood requirements by:
- Eliminating re-sticks due to delays with multi-use analyzers
- Minimizing the risk of sample clotting before and during testing
- Consolidating analytes on one cartridge
your ideal diagnostic solution
With a broad menu of tests on a single bedside platform, i-STAT can help reduce process inefficiencies, improve hospital supply/PPE utilization, and enhance protection for patients and staff.
support high-quality care
- Informs critical decisions at the patient's bedside
- Promotes collaborative, patient-centric care
- Enables rapid treatment decisions
- Reduces vent weaning time
enhance efficiency
- Reduces complex steps and streamlines workflow
- Optimizes resource utilization, including PPE conservation
- Provides portability and flexibility
- Helps meet surge demand
- Enables use in non-traditional ICU settings
help increase patient
& staff safety
- Offers excellent precision and lab-quality results
- Reduces risk of sample handling errors
- Supports infection prevention
- Decreases travel between areas of the hospital
- Simple disinfection protocol and singile-use cartidges
real-world evidence
Implementing bedside testing helped the critical care team in a New York City hospital significantly improve performance across multiple measures of success2,3
decreased incidence of infections to
0%
decreased blood product utilization by
36%
decreased mean mechanical vent time to
160 min
reduced length of
stay by
44%
lowered mortality
rate by
0.1%
reduced total costs of care by
47%
The results shown here are specific to one healthcare facility and may differ from those achieved by other institutions.
real-world evidence
Implementing bedside testing helped the critical care team in a New York City hospital significantly improve performance across multiple measures of success2,3
decreased incidence of infections to
0%
decreased blood product utilization by
36%
decreased mean mechanical vent time to
160 min
reduced length of
stay by
44%
lowered mortality
rate by
0.1%
reduced total costs of care by
47%
The results shown here are specific to one healthcare facility and may differ from those achieved by other institutions.
NEONATAL ICU |
Respiratory Therapy |
Cardiovascular or |
Cardiovascular icu |
CATH LAB |
NEONATAL ICU |
Respiratory Therapy |
Cardiovascular or |
Cardiovascular icu |
CATH LAB |
supporting care during a pandemic
"Any time our care team members enter or exit the COVID-19 ICU, it increases risk of cross contamination and uses another set of PPE. So every test that can be run at the point of care, we do."
VICKI CARVER, MANAGER OF RESPIRATORY THERAPY PULMONARY DIAGNOSTICS SERVICES AND EKG
- Aligns with CDC recommendations stating that whenever possible, perform procedures/tests in the patient's room.3
- Helps meet surge demand, even during peak times
- Enables use in non-traditional ICU settings
- Drives efficiency and PPE conservation
- Helps reduce infection risk
- Eliminates sample transport throughout the hospital
- Limits exposure to potentially infectious bodily fluids during testing
- Facilitates reduction in time on mechanical ventilation and associated risks
References
- Stokowski, LA et al. Anaema and erythrocyte transfusions in neonates. www.medscape.org/viewarticle/584656. Accessed July 2022.
- 055323 Rev A_Charles Oribabor: The Role of Point of Care Testing in Cardiac Surgery Intensive Care. Data on File with Abbott Point of Care.
- Charles Oribabor New York Methodist Cardiac Surgery: 2010 Program Outcomes - NY State Data.
- Infection Control: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Centers for Disease Control and Prevention, July, 2020
